Awm Investment Company, Inc. Spero Therapeutics, Inc. Transaction History

Awm Investment Company, Inc.

$732 Million
Q3 2024

A detailed history of Awm Investment Company, Inc. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 333,400 shares of SPRO stock, worth $320,064. This represents 0.06% of its overall portfolio holdings.

Number of Shares

333,400

Previous 333,400 -0.0%

Holding current value

$320,064

Previous $433,000 3.0%

% of portfolio

0.06%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.2 - $1.63 $60,000 - $81,500	-50,000 Reduced 13.04%	333,400 $403,000
Q2 2023 Aug 11, 2023	SELL	$1.42 - $1.95 $1.3 Million - $1.79 Million	-917,000 Reduced 70.52%	383,400 $555,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.12 $1.55 Million - $2.12 Million	-1,000,000 Reduced 43.47%	1,300,400 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $1.56 Million - $5.06 Million	2,300,400 New	2,300,400 $4.6 Million
Q2 2022 Aug 12, 2022	SELL	$0.74 - $7.44 $275,838 - $2.77 Million	-372,755 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$11.65 - $22.07 $1.47 Million - $2.78 Million	-126,000 Reduced 25.26%	372,755 $7.23 Million
Q3 2020 Nov 13, 2020	BUY	$8.96 - $14.12 $2.28 Million - $3.6 Million	255,000 Added 104.61%	498,755 $5.57 Million
Q2 2020 Aug 13, 2020	SELL	$7.27 - $14.18 $1.11 Million - $2.16 Million	-152,194 Reduced 38.44%	243,755 $3.3 Million
Q1 2020 May 15, 2020	SELL	$5.27 - $10.41 $413,141 - $816,091	-78,395 Reduced 16.53%	395,949 $3.2 Million
Q4 2019 Feb 13, 2020	SELL	$9.46 - $12.16 $1.17 Million - $1.51 Million	-123,971 Reduced 20.72%	474,344 $4.56 Million
Q2 2019 Aug 08, 2019	BUY	$10.25 - $14.36 $369,194 - $517,232	36,019 Added 6.41%	598,315 $6.89 Million
Q1 2019 May 14, 2019	BUY	$6.26 - $13.31 $239,576 - $509,387	38,271 Added 7.3%	562,296 $7.2 Million
Q4 2018 Feb 13, 2019	SELL	$5.69 - $11.28 $93,594 - $185,544	-16,449 Reduced 3.04%	524,025 $3.22 Million
Q3 2018 Nov 09, 2018	BUY	$9.69 - $17.79 $3.88 Million - $7.12 Million	400,000 Added 284.75%	540,474 $5.68 Million
Q2 2018 Aug 09, 2018	SELL	$10.41 - $17.85 $2.18 Million - $3.74 Million	-209,526 Reduced 59.86%	140,474 $2.06 Million
Q4 2017 Feb 13, 2018	BUY	$10.43 - $14.75 $3.65 Million - $5.16 Million	350,000	350,000 $4.11 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.

Account

Awm Investment Company, Inc. Spero Therapeutics, Inc. Transaction History